On June 9, 2025, Alaunos Therapeutics, Inc. amended a warrant agreement with Mast Hill Fund, modifying terms such as adding a price floor of $0.57 per share. This amendment affects stock rights related to certain transactions but does not significantly alter the number of shares issuable under the warrant.